<< All Speakers

Julien Penders

Co-Founder & COO, Bloomlife

Julien Penders is co-founder and COO at Bloomlife, an award-winning women’s health company solving one of the most significant yet underserved global challenges today, maternal health.  Bloomlife combines its FDA-cleared prenatal wearable with connected devices and data analytics to increase access to care, provide personalized feedback to moms, and help doctors earlier predict and manage pregnancy complications.
 
Julien is the proud dad of 3 children who were the inspiration to create Bloomlife. Julien is a passionate entrepreneur, operator, startup mentor and early-stage angel investor with 20-year experience in med-tech, health-tech and digital health. He led international teams through the development of medical devices and digital health products for the cardiac, neurological and wellness industry, with responsibilities covering hardware, software, analytics, clinical, regulatory, manufacturing and commercialization.
 
Julien has (co-)authored over 60 papers and 14 patents. He is a TEDx and Creativity World Forum speaker, and an EMBS Distinguished Speaker. He serves on the IEEE Technical Committee on Biomedical Health Informatics, and sits on the Program Committees for several international conferences. Julien was a 2004/2005 fellow of the Belgian American Educational Foundation. He holds a M.Sc. degree in Engineering Physics from University of Liege, Belgium (2004), and a M.Sc. degree in Biomedical Engineering from Boston University, MA (2006).

Session:

How to build a MedTech Valley in Belgium ?

Location Einstein ABC Room Start / end time 11:15 am to 11:45 am

Let’s reflect on the current situation in Belgium to determine if it is indeed or not yet a fertile ground for medical technologies innovation.

With the cross view of companies leaders and other stakeholders, we will discuss the elements that are contributing or missing to further promote a Belgian MedTech Valley. We will also get some insights from abroad examples and inspiration from the pharma valley.

The open discussion with the panel members will lead to call for actions and provide food for thoughts to pave the way for an even brighter future.